R.J. Stubbs
Papers
1
Total Citations
15
H-Index
1
About
R.J. Stubbs is a biochemist and analytical chemist whose work has centered on the development of sensitive, automated methods for drug quantification in biological matrices. His most cited research, published in 1995, introduced a high-performance liquid chromatographic (HPLC) technique for measuring the neuraminidase inhibitor GG167 in human serum. By employing pre-column fluorescence derivatisation with benzoin, Stubbs achieved the high sensitivity required to track this antiviral compound, which was later developed into the influenza drug zanamivir (Relenza). This method, cited 15 times, exemplifies his contribution to bioanalytical chemistry: creating robust, automated protocols that bridge drug discovery and clinical pharmacokinetics. While his citation count is modest, the work reflects a focused expertise in analytical method development for emerging therapeutics, particularly in virology. Stubbs’ approach—combining chemical derivatisation with automated HPLC—provided a practical tool for researchers studying neuraminidase inhibitors, enabling precise serum-level measurements that supported early-stage clinical trials. His legacy lies in demonstrating how careful analytical design can accelerate the translation of novel drugs from bench to bedside.
Research Focus
Key Achievements
Top Papers
- 1